微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 71.07% | -2.74% | -0.05% | 25/56 | 53.56% | 荣昌生物 | 95.71% | 行业排名> |
| 2026-03-31 | 71.11% | -5.81% | -0.89% | 25/56 | 60.48% | 我武生物 | 95.25% | 行业排名> |
| 2025-12-31 | 71.75% | -4.38% | -2.53% | 26/56 | 64.39% | 我武生物 | 95.24% | 行业排名> |
| 2025-09-30 | 73.61% | -4.25% | 0.73% | 25/56 | 66.5% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 73.07% | -4.93% | -3.2% | 26/56 | 67.83% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 75.49% | -4.06% | 0.6% | 24/56 | 36.56% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 75.04% | 1.08% | -2.39% | 23/56 | 67.21% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 76.87% | 3.87% | 0.02% | 21/56 | 69.22% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 76.86% | 1.37% | -2.32% | 19/56 | 68.29% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 78.68% | -1.81% | 5.99% | 19/56 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 74.23% | -3.4% | 0.3% | 25/56 | 67.71% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 74.01% | -4.07% | -2.39% | 26/56 | 67.65% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 75.83% | -2.77% | -5.37% | 23/56 | 62.76% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 80.13% | -3.96% | 4.27% | 21/56 | 69.01% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 76.85% | -3.16% | -0.39% | 23/56 | 19.27% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 77.15% | -3.25% | -1.08% | 23/56 | 70.88% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 77.99% | -3.52% | -6.53% | 22/56 | 68.78% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 83.44% | -0.77% | 5.14% | 19/56 | 71.21% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 79.36% | -6.65% | -0.48% | 27/56 | 71.82% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 79.74% | -5.14% | -1.35% | 28/56 | 73.6% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 80.83% | -5.67% | -3.87% | 25/56 | 73.47% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 84.08% | -3.71% | -1.09% | 17/56 | 72.72% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 85.01% | -3.33% | 1.13% | 21/56 | 71.4% | 义翘神州 | 96.88% | 行业排名> |
| 2020-09-30 | 84.06% | -4.45% | -1.91% | 16/56 | 73.45% | 义翘神州 | 96.56% | 行业排名> |
| 2020-06-30 | 85.69% | -2.25% | -1.87% | 17/56 | 88.43% | 华兰疫苗 | 707.43% | 行业排名> |
| 2020-03-31 | 87.32% | -2.45% | -0.7% | 11/56 | 70.22% | 我武生物 | 95.6% | 行业排名> |
| 2019-12-31 | 87.94% | 14.65% | -0.04% | 13/56 | 72.45% | 我武生物 | 96.43% | 行业排名> |
| 2019-09-30 | 87.97% | 0.94% | 0.35% | 8/56 | 70.09% | 我武生物 | 96.51% | 行业排名> |
| 2019-06-30 | 87.66% | 1.9% | -2.07% | 5/56 | 69.35% | 我武生物 | 96.46% | 行业排名> |
| 2019-03-31 | 89.52% | 1.2% | 16.71% | 5/56 | 69.07% | 我武生物 | 96.44% | 行业排名> |
| 2018-12-31 | 76.7% | 60.93% | -11.99% | 23/56 | 71.51% | 康辰药业 | 95.1% | 行业排名> |
| 2018-09-30 | 87.16% | 82.95% | 1.31% | 6/56 | 67.51% | 康辰药业 | 94.98% | 行业排名> |
| 2018-06-30 | 86.03% | 81.06% | -2.74% | 6/56 | 67.03% | 康辰药业 | 94.9% | 行业排名> |
| 2018-03-31 | 88.45% | 123.32% | 85.58% | 5/56 | 65.03% | 我武生物 | 93.37% | 行业排名> |
| 2017-12-31 | 47.66% | 33.63% | 0.05% | 30/56 | -915.2% | 我武生物 | 96.35% | 行业排名> |
| 2017-09-30 | 47.64% | 111.08% | 0.26% | 19/56 | 65.93% | 我武生物 | 97% | 行业排名> |
| 2017-06-30 | 47.51% | 117.27% | 19.96% | 21/56 | 63.83% | 我武生物 | 96.96% | 行业排名> |
| 2017-03-31 | 39.61% | 187.18% | 11.05% | 19/56 | 65.37% | 我武生物 | 97.16% | 行业排名> |
| 2016-12-31 | 35.67% | -30.57% | 58.04% | 26/56 | 68.26% | 欧林生物 | 99.46% | 行业排名> |
| 2016-09-30 | 22.57% | -55.95% | 3.2% | 19/56 | 63.02% | 我武生物 | 95.96% | 行业排名> |
| 2016-06-30 | 21.87% | -63.27% | 58.56% | 22/56 | -3007.12% | 欧林生物 | 99.4% | 行业排名> |
| 2016-03-31 | 13.79% | -71.22% | -73.15% | 20/56 | 61.6% | 我武生物 | 95.8% | 行业排名> |